As May unfolds, allergists and public health advocates are renewing calls for improved asthma care access—a message that carries particular weight in regions where this chronic respiratory condition remains a leading cause of preventable death.

According to the American College of Allergy, Asthma and Immunology, the annual awareness campaign aims to close knowledge gaps that contribute to poor disease management. But the challenge extends far beyond patient education. Globally, asthma affects an estimated 262 million people, yet access to even basic controller medications remains starkly unequal.

The Treatment Gap

The World Health Organization reports that approximately 455,000 people died from asthma in 2019, with more than 80% of these deaths occurring in low- and lower-middle-income countries. This disparity persists despite the availability of effective, relatively inexpensive treatments that can control symptoms and prevent fatal attacks.

"We have the tools to manage asthma effectively," said Dr. Kathleen May, an allergist and immunologist based in Minneapolis, as reported by the ACAAI. "The tragedy is that so many people—both in wealthy nations and developing countries—either don't have access to proper treatment or don't understand how to use it correctly."

The medications that form the cornerstone of asthma management—inhaled corticosteroids and bronchodilators—have been around for decades. Yet supply chain issues, prohibitive costs, and lack of healthcare infrastructure mean millions of patients worldwide cannot obtain them reliably.

Beyond Medication Access

Medical specialists emphasize that effective asthma management requires more than just medication availability. It demands patient education, environmental interventions, and regular monitoring—resources that remain scarce in many communities.

In urban areas across South Asia and sub-Saharan Africa, air pollution exacerbates respiratory conditions while healthcare systems struggle to provide consistent care. A 2024 study published in The Lancet Respiratory Medicine found that children in high-pollution urban environments face asthma rates up to three times higher than their rural counterparts, yet often have less access to specialized care.

Trigger identification and avoidance—a fundamental aspect of asthma management—requires resources many families cannot afford. Dust mite-proof bedding, air purifiers, and even the ability to control indoor humidity are often luxuries in communities where households face more immediate survival concerns.

The Allergy Connection

Allergists note that asthma frequently coexists with allergic conditions, creating a complex management challenge. Seasonal allergies, food allergies, and eczema often appear together, particularly in children, requiring comprehensive care approaches that address multiple conditions simultaneously.

"We're seeing increasing rates of allergic diseases globally," explained Dr. James Chen, a pediatric allergist quoted in the ACAAI release. "Understanding the connections between these conditions helps us treat patients more effectively, but it also means we need healthcare systems equipped to provide that level of care."

The rising prevalence of allergic diseases correlates with urbanization and lifestyle changes—phenomena accelerating rapidly in developing economies. Yet specialist training in allergy and immunology remains concentrated in wealthy nations, creating a provider shortage precisely where disease burden is increasing fastest.

Climate Change as a Multiplier

Climate change is extending pollen seasons and introducing new allergens to regions previously unaffected, according to recent environmental health research. Warmer temperatures and increased carbon dioxide levels cause plants to produce more pollen over longer periods, intensifying symptoms for allergy and asthma sufferers.

For vulnerable populations—including children, elderly individuals, and those with limited healthcare access—these environmental shifts compound existing health inequities. Communities already struggling with inadequate medical infrastructure now face evolving environmental triggers that worsen respiratory conditions.

What Patients Need to Know

Despite systemic challenges, allergists emphasize several key messages for individuals managing asthma and allergies. Controller medications must be taken daily as prescribed, even when symptoms aren't present—a concept many patients struggle to maintain. Rescue inhalers treat acute symptoms but don't address underlying inflammation.

Recognizing warning signs of worsening asthma—including increased nighttime symptoms, more frequent rescue inhaler use, and difficulty completing normal activities—can prevent dangerous escalations. Emergency action plans, developed with healthcare providers, should outline specific steps for managing deteriorating symptoms.

For allergies, identifying specific triggers through proper testing enables targeted avoidance strategies and appropriate treatment. Many patients self-diagnose incorrectly or rely on ineffective over-the-counter remedies when prescription options might provide better relief.

The Path Forward

Public health experts argue that addressing asthma and allergy disparities requires multi-level interventions. National health systems must prioritize respiratory disease in resource allocation. International organizations need to ensure essential medications reach underserved populations. Communities require education programs that empower patients to advocate for their health needs.

"Awareness months serve an important purpose," noted Dr. May, "but awareness without action perpetuates inequity. We need sustained commitment to making effective asthma and allergy care accessible to everyone who needs it, regardless of where they live or their economic circumstances."

As climate patterns shift and urbanization continues, the global burden of respiratory and allergic diseases will likely increase. Whether health systems can adapt to meet these challenges—particularly for the world's most vulnerable populations—remains an open question with profound implications for millions of lives.